483
Medtronic NeuromodulationMedtronic Neuromodulation – FDA 483, Jan 21, 2011
Record Details
An FDA inspection of Medtronic Neuromodulation in Minneapolis, MN, revealed significant deficiencies in quality system processes. The firm failed to adequately validate manufacturing processes and product designs, and exhibited severe issues with complaint handling and corrective and preventive action documentation. These observations indicate a systemic breakdown in ensuring product quality and safety.
View Company Profile
ID · f21b8cb5-3478-4780-aec4-4e5833994a7e
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.